Replies to post #345803 on Anavex Life Sciences Corp (AVXL)

[hebbeke47]

9:30 am Using Precision Medicine in Clinical Trials to Advancing Therapeutics for both Degenerative & Rare Mitochondrial Diseases

Christopher Missling
President & Chief Executive Officer, Anavex Life Sciences Corp
Synopsis

Assessing clinical data with biomarker-correlated outcomes of ANAVEX2-73 (blarcamesine) in Alzheimer’s, Parkinson’s, and Rett Syndrome
Reviewing mechanistic analysis of involvement of mitochondrial function